131I-labeled engineered hybrid cell membrane biomimetic nanocarrier targets gastric cancer and enhances radioimmunotherapy

Chuanqiang Zhang, Hua Chen, Zheng Yuan, Anqi Dong, Shu Liu, Lin Hu, Kai Yang, Jin Zhou

Open source

DOI
10.1016/j.mtbio.2026.103533
Published
2026-10
Container
Materials Today Bio
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.mtbio.2026.103533,
  title = {131I-labeled engineered hybrid cell membrane biomimetic nanocarrier targets gastric cancer and enhances radioimmunotherapy},
  author = {Chuanqiang Zhang and Hua Chen and Zheng Yuan and Anqi Dong and Shu Liu and Lin Hu and Kai Yang and Jin Zhou},
  year = {2026},
  journal = {Materials Today Bio},
  doi = {10.1016/j.mtbio.2026.103533},
  url = {https://doi.org/10.1016/j.mtbio.2026.103533}
}

RIS

TY  - JOUR
TI  - 131I-labeled engineered hybrid cell membrane biomimetic nanocarrier targets gastric cancer and enhances radioimmunotherapy
AU  - Chuanqiang Zhang
AU  - Hua Chen
AU  - Zheng Yuan
AU  - Anqi Dong
AU  - Shu Liu
AU  - Lin Hu
AU  - Kai Yang
AU  - Jin Zhou
PY  - 2026
JO  - Materials Today Bio
DO  - 10.1016/j.mtbio.2026.103533
UR  - https://doi.org/10.1016/j.mtbio.2026.103533
ER  - 

APA

Zhang, C., Chen, H., Yuan, Z., Dong, A., Liu, S., Hu, L., Yang, K., & Zhou, J. (2026). 131I-labeled engineered hybrid cell membrane biomimetic nanocarrier targets gastric cancer and enhances radioimmunotherapy. Materials Today Bio. https://doi.org/10.1016/j.mtbio.2026.103533

Source records